{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:35:51Z","timestamp":1791326151514,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd006688","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T00:00:00Z","timestamp":1297814400000}}],"reference-count":61,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006688.pub2","type":"journal-article","created":{"date-parts":[[2011,2,4]],"date-time":"2011-02-04T13:41:01Z","timestamp":1296826861000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Azithromycin for treating uncomplicated malaria"],"prefix":"10.1002","volume":"2019","author":[{"given":"Anna M","family":"van Eijk","sequence":"first","affiliation":[{"name":"Liverpool School of Tropical Medicine; Child & Reproductive Health Group; Pembroke Place Liverpool UK L3 5QA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne J","family":"Terlouw","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine; Child & Reproductive Health Group; Pembroke Place Liverpool UK L3 5QA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,16]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD006688.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4269\/ajtmh.2005.73.1108","article-title":"A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India","volume":"73","author":"Dunne","year":"2005","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"10","key":"10.1002\/14651858.CD006688.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/429343","article-title":"A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India","volume":"191","author":"Dunne","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006688.pub2-BIB0003|cit3","first-page":"801","article-title":"A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand","volume":"31","author":"Krudsood","year":"2000","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"3","key":"10.1002\/14651858.CD006688.pub2-BIB0004|cit4","first-page":"525","article-title":"A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria","volume":"33","author":"Krudsood","year":"2002","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"3","key":"10.1002\/14651858.CD006688.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4269\/ajtmh.2006.74.401","article-title":"Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose ranging study","volume":"74","author":"Miller","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"3","key":"10.1002\/14651858.CD006688.pub2-BIB0006|cit6","first-page":"522","article-title":"Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria","volume":"27","author":"Na-Bangchang","year":"1996","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1086\/508175","article-title":"Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: A randomized, phase 2 clinical trial in Thailand","volume":"43","author":"Noedl","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0008|cit8","article-title":"A three day trial of azithromycin plus chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria","author":"Pfizer Inc","year":"2008","journal-title":"http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00282919"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0009|cit9","unstructured":"Pfizer Inc A phase-3, randomized, open-label, comparative trial of azithromycin plus chloroquine versus mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa http:\/\/pdf.clinicalstudyresults.org\/documents\/company-study_4619_0.pdf 2008"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0010|cit10","unstructured":"Pfizer Inc A phase 2\/3 randomized, comparative trial of azithromycin plus chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in India http:\/\/pdf.clinicalstudyresults.org\/documents\/company-study_1101_0.pdf 2007"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0011|cit11","article-title":"A phase 2, double blind, randomized, comparative trial of azithromycin in combination with chloroquine versus chloroquine in the eradication of asymptomatic Plasmodium falciparum infection in semi-immune adults","author":"Pfizer Inc","year":"2007","journal-title":"http:\/\/pdf.clinicalstudyresults.org\/documents\/company-study_1764_0.pdf"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0012|cit12","unstructured":"Pfizer Inc A phase 2\/3, randomized, double-blind, comparative trial of azithromycin plus chloroquine versus mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa http:\/\/pdf.clinicalstudyresults.org\/documents\/company-study_2362_0.pdf 2007"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0013|cit13","unstructured":"Pfizer Inc A phase 2\/3, randomized, double blind, comparative trial of azithromycin plus chloroquine versus atovaquone-proguanil for the treatment of uncomplicated Plasmodium falciparum malaria in South America http:\/\/pdf.clinicalstudyresults.org\/documents\/company-study_1770_0.pdf 2007"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0014|cit14","unstructured":"Pfizer Inc A phase 2\/3, randomized, comparative, double blind trial of azithromycin plus chloroquine versus sulfadoxine-pyrimethamine plus chloroquine for the treatment of uncomplicated, symptomatic falciparum malaria in Southeast Asia http:\/\/pdf.clinicalstudyresults.org\/documents\/company-study_1765_0.pdf 2007"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0035-9203(01)90027-6","article-title":"Therapeutic responses to antibacterial drugs in vivax malaria","volume":"95","author":"Pukrittayakamee","year":"2001","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/605635","article-title":"Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplications malaria in Tanzanian children: a randomized, controlled trial","volume":"49","author":"Sykes","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006688.pub2-BIB0017|cit17","article-title":"Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized controlled clinical trial","volume":"202","author":"Thriemer","year":"2010","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0018|cit18","unstructured":"National Institute of Allergy and Infectious Diseases Chloroquine alone or in combination for malaria in children in Malawi http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00379821. 2006"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0019|cit19","unstructured":"Pfizer Inc Azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated P. falciparum malaria in children in Africa http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00677833. 2008"},{"issue":"2","key":"10.1002\/14651858.CD006688.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0029-7844(97)00586-3","article-title":"Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin","volume":"91","author":"Adair","year":"1998","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD006688.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.1995.52.159","article-title":"Activity of azithromycin as a blood schizonticide against rodent and human plasmodium in vivo","volume":"52","author":"Andersen","year":"1995","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1086\/516281","article-title":"Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in Western Kenya","volume":"26","author":"Andersen","year":"1998","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006688.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pt.2007.11.008","article-title":"Antimalarial dosing regimens and drug resistance","volume":"24","author":"Barnes","year":"2008","journal-title":"Trends in Parasitology"},{"issue":"4","key":"10.1002\/14651858.CD006688.pub2-BIB0024|cit24","first-page":"240","article-title":"In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum","volume":"47","author":"Biswas","year":"2001","journal-title":"Journal of Postgraduate Medicine"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0025|cit25","volume-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria [WHO\/HTM\/RBM\/2003.50]","author":"Bloland","year":"2003"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/S0924-8579(05)80320-6","article-title":"Evolution of a new drug formulation: the rationale for high-dose, short-course therapy with azithromycin","volume":"26 Suppl 3","author":"Blumer","year":"2005","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1475-2875-7-255","article-title":"Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy","volume":"7","author":"Chico","year":"2008","journal-title":"Malaria Journal"},{"issue":"6","key":"10.1002\/14651858.CD006688.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pt.2008.03.007","article-title":"Apicoplast translation, transcription and genome replication: targets for antimalarials antibiotics","volume":"24","author":"Dahl","year":"2008","journal-title":"Trends in Parasitology"},{"issue":"6","key":"10.1002\/14651858.CD006688.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1128\/AAC.01370-08","article-title":"Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr Green I-based fluorescence assay","volume":"53","author":"Edgie-Mark","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD006688.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.1992.47.378","article-title":"Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine resistant strains of Plasmodium falciparum in vitro","volume":"47","author":"Gingras","year":"1992","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD006688.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4269\/ajtmh.1993.49.101","article-title":"Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei","volume":"49","author":"Gingras","year":"1993","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD006688.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1067\/mob.2001.118158","article-title":"Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda","volume":"185","author":"Gray","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD006688.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4269\/ajtmh.2005.73.842","article-title":"Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in western Thailand","volume":"73","author":"Heppner","year":"2005","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0034|cit34","unstructured":"Higgins JPT Altman DG (editors) Chapter 8: Assessing risk of bias in included studies Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Collaboration"},{"issue":"1","key":"10.1002\/14651858.CD006688.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1371\/journal.pmed.0050020","article-title":"CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration","volume":"5","author":"Hopewell","year":"2008","journal-title":"PLoS Medicine"},{"issue":"7303","key":"10.1002\/14651858.CD006688.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"British Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD006688.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"e1 166","DOI":"10.1371\/journal.pone.0001166","article-title":"A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women","volume":"2","author":"Kalilani","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.actatropica.2006.10.008","article-title":"Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro","volume":"100","author":"Nakornchai","year":"2006","journal-title":"Acta Tropica"},{"issue":"3-4","key":"10.1002\/14651858.CD006688.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.exppara.2004.05.005","article-title":"Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice","volume":"107","author":"Neerja","year":"2004","journal-title":"Experimental Parasitology"},{"issue":"1","key":"10.1002\/14651858.CD006688.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0001-706X(01)00141-3","article-title":"Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand","volume":"80","author":"Noedl","year":"2001","journal-title":"Acta Tropica"},{"issue":"2","key":"10.1002\/14651858.CD006688.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/AAC.01023-06","article-title":"In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome","volume":"51","author":"Noedl","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD006688.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488606775252584","article-title":"Antimalarial drugs in pregnancy: a review","volume":"1","author":"Nosten","year":"2006","journal-title":"Current Drug Safety"},{"issue":"1","key":"10.1002\/14651858.CD006688.pub2-BIB0043|cit43","first-page":"12","article-title":"Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery","volume":"8","author":"Ogasawara","year":"1999","journal-title":"Journal of Maternal-Fetal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD006688.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.46.8.2518-2524.2002","article-title":"Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro","volume":"46","author":"Ohrt","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0045|cit45","unstructured":"Pfizer Labs Zmax U.S. Physician Prescribing Information http:\/\/media.pfizer.com\/files\/products\/uspi_zmax.pdf. 2008"},{"issue":"6","key":"10.1002\/14651858.CD006688.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/AAC.45.6.1746-1750.2001","article-title":"In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron","volume":"45","author":"Pradines","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD006688.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/expr.1999.4465","article-title":"Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys","volume":"94","author":"Puri","year":"2000","journal-title":"Experimental Parasitology"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0924-8579(01)00401-0","article-title":"Macrolides: structures and microbial target","volume":"18","author":"Retsema","year":"2001","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0049|cit49","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2003"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"issue":"25","key":"10.1002\/14651858.CD006688.pub2-BIB0051|cit51","first-page":"1","article-title":"From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia","volume":"7","author":"Sipilanyambe","year":"2008","journal-title":"Malaria Journal"},{"issue":"11","key":"10.1002\/14651858.CD006688.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/AAC.48.11.4271-4280.2004","article-title":"In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow up","volume":"48","author":"Stepniewska","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/515071","article-title":"Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia","volume":"28","author":"Taylor","year":"1999","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006688.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00002018-200427010-00003","article-title":"Antimalarial drug toxicity","volume":"27","author":"Taylor","year":"2004","journal-title":"Drug Safety"},{"issue":"23","key":"10.1002\/14651858.CD006688.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1001\/jama.297.23.2603","article-title":"Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review","volume":"297","author":"Ter Kuile","year":"2007","journal-title":"Journal of the American Medical Association"},{"issue":"10","key":"10.1002\/14651858.CD006688.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S1471-4922(02)02373-5","article-title":"The assessment of antimalarial drug efficacy","volume":"18","author":"White","year":"2002","journal-title":"Trends in Parasitology"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0057|cit57","unstructured":"WHO Chemotherapy of malaria and resistance to antimalarials WHO Technical Report Series 1973"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0058|cit58","unstructured":"WHO Global Malaria Programme Global antimalarial drug policy database http:\/\/www.who.int\/malaria\/amdp\/amdp_afro.html. http:\/\/www.who.int\/malaria\/amdp\/amdp_searo.html. 2008"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0059|cit59","unstructured":"World Health Organization\/AFRO Severe malaria in the African region: results of a multicentre study Liaison Bulletin of the Malaria Programme WHO\/AFRO 2001 1 3"},{"key":"10.1002\/14651858.CD006688.pub2-BIB0060|cit60","volume-title":"Guidelines for the treatment of malaria [WHO\/HTM\/MAL\/2006.1108]","author":"World Health Organization","year":"2006"},{"issue":"4","key":"10.1002\/14651858.CD006688.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0020-7519(94)00119-9","article-title":"Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro","volume":"25","author":"Yeo","year":"1995","journal-title":"International Journal for Parasitology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006688.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T22:17:41Z","timestamp":1755901061000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006688.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,16]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006688.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,16]]}}}